LAG3 and B-cell chronic lymphocytic leukemia: However, in patients with chronic lymphocytic leukaemia (CLL), where sLAG-3 levels were higher in patients whose disease had progressed compared to those with stable CLL, sLAG-3 production was able to be attributed to the malignant B cells themselves [80].